Concepedia

Theresa Heah

TH

Statistics

Publications

12

Citations

1.6K

H-Index

12

Active since

2014

Affiliations

Aerie Pharmaceuticals (United States)(Current)

Duke University

Minnesota Eye Consultants

Icahn School of Medicine at Mount Sinai

University of California, Davis

Theresa Heah is an author at Aerie Pharmaceuticals (United States) specializing in ocular pharmacology, glaucoma, and ocular hypertension treatment.

Publications per year

2014–2021

12

Publications

12

Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration

Frank G. Holz, Ramin Tadayoni, Stephen Beatty et al. · British Journal of Ophthalmology · 2014 · 613 citations · Full text

, , +17

Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)

Janet B. Serle, L. Jay Katz, Eugene McLaurin et al. · American Journal of Ophthalmology · 2017 · 265 citations · Full text

, , +13

The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans

Arash Kazemi, Jay W. McLaren, Casey Kopczynski et al. · Journal of Ocular Pharmacology and Therapeutics · 2018 · 115 citations · Full text

, , +16

Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)

Malik Y. Kahook, Janet B. Serle, Francis S. Mah et al. · American Journal of Ophthalmology · 2019 · 115 citations

, , +13

Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study

Albert S Khouri, Janet B. Serle, Jason Bacharach et al. · American Journal of Ophthalmology · 2019 · 105 citations

, , +17

1–5 of 12